AmplifiDx
PrivateLast Round
Grant
Apr 15, 2026
Total Funding Raised
$2.43M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
AmplifiDx is a life sciences company that develops molecular point-of-care diagnostic platforms for the rapid detection of infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AmplifiDx Comparables
Compare AmplifiDx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Anavasi Diagnostics | 90% | |
| Alveo Technologies | 83% | |
| QuidelOrtho | 82% |
AmplifiDx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 15, 2026 | ||||
| Grant | Dec 3, 2024 | ||||
| Grant | May 15, 2023 | ||||
| Seed | Jul 23, 2021 |
Key People
Founding team and executive leadership
AmplifiDx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Biomedical Imaging and Bioengineering | Grant |
| Shepherd Ventures III | Seed |
| National Institute of Allergy and Infectious Diseases | Grant |
| Beacon Angels | Seed |
| Avestria Ventures | Seed |
| National Institutes of Health (NIH) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 20, 2026
Monthly visitors grew 494% MoM, from 34 to 202.
- Apr 15, 2026
$100K grant from National Institutes of Health (NIH).
AmplifiDx Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about AmplifiDx's valuation, stock price, and market status.
Is AmplifiDx a public or private company?
AmplifiDx is a private company.
What is the current stock price of AmplifiDx?
AmplifiDx is a private company with no public stock price. Caplight tracks AmplifiDx's secondary market activity and provides MarketPrice estimates to Caplight users.
How much is AmplifiDx worth (valuation)?
Valuation information for AmplifiDx is not publicly available.
Can I buy AmplifiDx stock?
AmplifiDx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was AmplifiDx's last funding round?
AmplifiDx's most recent funding round was Grant on April 15, 2026.
Who are the main investors in AmplifiDx?
Key investors in AmplifiDx include National Institute of Biomedical Imaging and Bioengineering, Shepherd Ventures III, National Institute of Allergy and Infectious Diseases, Beacon Angels, Avestria Ventures.
Will AmplifiDx IPO soon?
No public IPO plans have been announced for AmplifiDx.
How can I track AmplifiDx secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor AmplifiDx's secondary market activity and sign up for updates.